Evidence map›Paper›PMID 33613148›Full record

ReviewAdvanced functional materials2021

DNA Transformations for Diagnosis and Therapy.

So Yeon Ahn, Jin Liu, Srivithya Vellampatti, Yuzhou Wu, Soong Ho Um

Open access · greenAbstract readReview
In one paragraph

Review in Advanced functional materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. PhotocleavableChemical reviews · 2023
    Review
  5. The emergence of nanoporous materials in lung cancer therapy.Science and technology of advanced materials · 2022
    Review
  6. Review
  7. DNA Transformations for Diagnosis and Therapy.Advanced functional materials · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

So Yeon AhnSchool of Chemical Engineering Sungkyunkwan University 2066, Seobu-ro, Jangan-gu Suwon Gyeonggi-do 16419 Korea.
Jin LiuHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica School of Chemistry and Chemical Engineering Huazhong University of Science and Technology 1037 Luoyu Load Wuhan 430074 China.
Srivithya VellampattiInstitute of Convergent Chemical Engineering and Technology Sungkyunkwan University 2066, Seobu-ro, Jangan-gu Suwon Gyeonggi-do 16419 Korea.
Yuzhou WuHubei Key Laboratory of Bioinorganic Chemistry and Materia Medica School of Chemistry and Chemical Engineering Huazhong University of Science and Technology 1037 Luoyu Load Wuhan 430074 China.
Soong Ho UmSchool of Chemical Engineering SKKU Advanced Institute of Nanotechnology (SAINT) Biomedical Institute for Convergence at SKKU (BICS) and Institute of Quantum Biophysics (IQB) Sungkyunkwan University 2066, Seobu-ro, Jangan-gu Suwon Gyeonggi-do 16419 Korea.ORCID https://orcid.org/0000-0002-2910-5629
Huazhong University of Science and Technology · CNSungkyunkwan University · KRInstitute of Nanotechnology · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its unique physical and chemical characteristics, DNA, which is known only as genetic information, has been identified and utilized as a new material at an astonishing rate. The role of DNA has increased dramatically with the advent of various DNA derivatives such as DNA-RNA, DNA-metal hybrids, and PNA, which can be organized into 2D or 3D structures by exploiting their complementary recognition. Due to its intrinsic biocompatibility, self-assembly, tunable immunogenicity, structural programmability, long stability, and electron-rich nature, DNA has generated major interest in electronic and catalytic applications. Based on its advantages, DNA and its derivatives are utilized in several fields where the traditional methodologies are ineffective. Here, the present challenges and opportunities of DNA transformations are demonstrated, especially in biomedical applications that include diagnosis and therapy. Natural DNAs previously utilized and transformed into patterns are not found in nature due to lack of multiplexing, resulting in low sensitivity and high error frequency in multi-targeted therapeutics. More recently, new platforms have advanced the diagnostic ability and therapeutic efficacy of DNA in biomedicine. There is confidence that DNA will play a strong role in next-generation clinical technology and can be used in multifaceted applications.

Indexed as

DNA transformationnanomedicinesensingtheragnostics

Identifiers

PMID33613148
PMCPMC7883235
OpenAlexW3116352196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.